[1] SCRIMINI S, PONS J, SAULEDA J.Myeloid-derived suppressor cells: possible link between chronic obstructive pulmonary disease and lung cancer[J]. Archivos De Bronconeumología, 2016, 52(1): 29-35. [2] GRIVENNIKOV S I, GRETEN F R, KARIN M.Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6): 883-899. [3] MSPHLAT, BRAYF, SIEGELRL, et al. Globle cancer statistics 2012[J]. Ca A Cancer Journal for Clinicians, 2015, 65(2): 87-108. [4] KASALA E R, BODDULURU L N, BARUA C C, et al.Benzo(a)pyrene induced lung cancer: role of dietary phytochemicals in chemoprevention[J]. Pharmacological Reports, 2015, 67(5): 996-1009. [5] MANTOVANI A, ALLAVENA P, SICA A, et al.Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444. [6] HANAHAN D, WEINBERG R A.Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674. [7] SWARTZ M A, IIDA N, ROBERTS E W, et al.Tumor microenvironment complexity: emerging roles in cancer therapy: figure 1[J]. Cancer Research, 2012, 72(10): 2473-2480. [8] O'BYRNE K J, DALGLEISH A G. Chronic immune activation and inflammation as the cause of malignancy[J]. British Journal of Cancer, 2001, 85(4): 473-483. [9] SRIVASTAVA M K, ANDERSSON Å, ZHU L, et al.Myeloid suppressor cells and immune modulation in lung cancer[J]. Immunotherapy, 2012, 4(3): 291-304. [10] SERAFINI P, CARBLEY R, NOONAN K A, et al.High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells[J]. Cancer Research, 2004, 64(17): 6337-6343. [11] ZHANG C, LEI G S, SHAO S J, et al.Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia[J]. Infection and Immunity, 2012, 80(10): 3634-3641. [12] ANANDAKUMAR P, KAMARAJ S, JAGAN S, et al.Capsaicin inhibits benzo(a)pyrene-induced lung carcinogenesis in an in vivo mouse model[J]. Inflammation Research, 2012, 61(11): 1169-1175. [13] SHI M H, SHI G C, TANG J, et al.Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice[J]. Journal of Allergy and Clinical Immunology, 2014, 134(5): 1163-1174. [14] ELLIS J.The impact of lung cancer on patients and carers[J]. Chronic Respiratory Disease, 2012, 9(1): 39-47. [15] MILARA J, CORTIJO J.Tobacco, inflammation, and respiratory tract cancer[J]. Current Pharmaceutical Design, 2012, 18(26): 3901-3938. [16] KERKAR S P, RESTIFO N P.Cellular constituents of immune escape within the tumor microenvironment[J]. Cancer Research, 2012, 72(13): 3125-3130. [17] LI H Q, HAN Y M, GUO Q L, et al.Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1[J]. The Journal of Immunology, 2009, 182(1): 240-249. [18] ILKOVITCH D, LOPEZ D M.The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression[J]. Cancer Research, 2009, 69(13): 5514-5521. [19] POSCHKE I, MAO Y, ADAMSON L, et al.Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines[J]. Cancer Immunology, Immunotherapy, 2012, 61(6): 827-838. [20] SERAFINI P, CARBLEY R, NOONAN K A, et al.High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells[J]. Cancer Research, 2004, 64(17): 6337-6343. [21] YOUN J, NAGARAJ S, COLLAZO M, et al.Subsets of myeloid-derived suppressor cells in tumor-bearing mice[J]. The Journal of Immunology, 2008, 181(8): 5791-5802. |